The upregulation of NOX5 is implicated in several pathological conditions, including hypertension, diabetes, inflammation, and fibrosis, making it a promising target for improving cardiovascular and renal outcomes in diabetes [191]. The gene discussed is NOX5; the disease is Hypertension.